InDex Pharmaceuticals Holding AB (publ) - Current Ratio

The Current Ratio as of October 2026 (TTM) for InDex Pharmaceuticals Holding AB (publ) (INDEX.ST) is 66.45

According to InDex Pharmaceuticals Holding AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 66.45. This represents a change of -15.23% compared to the average of 78.39 of the last 4 quarters.

InDex Pharmaceuticals Holding AB (publ) (INDEX.ST) Historical Current Ratio (quarterly & annually)

How has INDEX.ST Current Ratio performed in the past?

The mean historical Current Ratio of InDex Pharmaceuticals Holding AB (publ) over the last ten years is 21.07. The current 66.45 Current Ratio has changed 31.44% with respect to the historical average. Over the past ten years (40 quarters), INDEX.ST's Current Ratio was at its highest in in the March 2025 quarter at 120.16. The Current Ratio was at its lowest in in the December 2023 quarter at 5.04.

InDex Pharmaceuticals Holding AB (publ) (INDEX.ST) Current Ratio by Quarter and Year

Discovering the peaks and valleys of InDex Pharmaceuticals Holding AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

InDex Pharmaceuticals Holding AB (publ) (INDEX.ST) Average Current Ratio

How has INDEX.ST Current Ratio performed in the past?

The current Current Ratio of InDex Pharmaceuticals Holding AB (publ) (INDEX.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

InDex Pharmaceuticals Holding AB (publ) (INDEX.ST) Current Ratio vs. Peers

How is INDEX.ST’s Current Ratio compared to its peers?

InDex Pharmaceuticals Holding AB (publ)’s Current Ratio is greater than Probi AB (publ) (6.94), greater than Abliva AB (publ) (4.13), less than Medivir AB (publ) (0), greater than Scandion Oncology A/S (1.81), greater than Promore Pharma AB (publ) (3.33), greater than CombiGene AB (publ) (8.85), greater than Kancera AB (publ) (10.03), greater than Amniotics AB (publ) (1.17), greater than ISR Immune System Regulation Holding AB (publ) (3.27), greater than Cyxone AB (publ) (4.01),

Build a custom stock screener for InDex Pharmaceuticals Holding AB (publ) (INDEX.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like InDex Pharmaceuticals Holding AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

InDex Pharmaceuticals Holding AB (publ) (INDEX.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like InDex Pharmaceuticals Holding AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.